치쿤구니야열 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 진단별, 치료별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)
Chikungunya Fever Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis, By Treatment, By End User, By Region and Competition, 2020-2030F
상품코드:1886473
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 치쿤구니야열 시장은 2024년에 4억 9,323만 달러로 평가되며, 2030년까지 CAGR 7.28%로 성장하며, 7억 5,191만 달러에 달할 것으로 예측됩니다. 세계 치쿤구니야열 시장은 주로 네타시모카 및 인간지카에 의해 매개되는 이 모기 매개 바이러스 감염에 대응하는 치료적 개입, 진단 솔루션, 예방 조치를 포함하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
4억 9,323만 달러
시장 규모 : 2030년
7억 5,191만 달러
CAGR : 2025-2030년
7.28%
가장 빠르게 성장하는 부문
혈청학적 검사
최대 시장
남미
주요 시장 성장 촉진요인
세계에서 증가하고 있는 치쿤구니야열의 발생률은 진단 툴, 치료 중재 및 예방 백신에 대한 시장 수요를 크게 견인하고 있습니다. 질병의 확산이 심각해짐에 따라 보다 광범위한 검사와 치료가 필요해짐에 따라 제품 개발이 가속화되고 있습니다.
주요 시장 과제
모니터링 능력과 진단 체계의 지속적인 격차는 전 세계 치쿤구니야열 시장 성장에 심각한 장벽으로 작용하고 있습니다. 이 문제는 질병의 적시 발견과 효과적인 관리를 지연시킴으로써 시장에 직접적인 악영향을 미치고 있으며, 진단 솔루션과 후속 치료 개입에 대한 수요를 제한하고 있습니다.
주요 시장 동향
mRNA 백신 기술의 발전은 항원의 신속한 식별과 유연한 제조 공정을 가능하게 함으로써 치쿤구니야 백신 개발 주기를 앞당기는 중요한 추세입니다. 이 기술은 새로운 바이러스 변종에 대한 신속한 대응이 가능하며, 높은 효능 프로파일의 가능성을 제공합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 치쿤구니야열 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
진단 방법별(ELISA 기반 검사, 혈청학적 검사, 바이러스학적 검사)
치료법별(알로파시, 동종요법, 아유르베다, 기타)
최종사용자별(병원·클리닉, 외래 수술 시설, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 치쿤구니야열 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 치쿤구니야열 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 치쿤구니야열 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 치쿤구니야열 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 치쿤구니야열 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 치쿤구니야열 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Quest Diagnostics, Inc.
Abbott Laboratories, Inc.
Genome Diagnostics Pvt. Ltd.
Altona Diagnostics GmbH
Bio-Rad Laboratories, Inc.
Taj Pharmaceuticals Ltd.
Etubics Corporation
Shanghai Solve Care Co. Ltd.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Chikungunya Fever Market, valued at USD 493.23 Million in 2024, is projected to experience a CAGR of 7.28% to reach USD 751.91 Million by 2030. The Global Chikungunya Fever Market encompasses therapeutic interventions, diagnostic solutions, and preventive measures addressing this mosquito-borne viral infection, primarily transmitted by *Aedes aegypti* and *Aedes albopictus* mosquitoes.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 493.23 Million
Market Size 2030
USD 751.91 Million
CAGR 2025-2030
7.28%
Fastest Growing Segment
Serological Tests
Largest Market
South America
Key Market Drivers
The rising global incidence of Chikungunya Fever significantly drives market demand for diagnostic tools, therapeutic interventions, and preventive vaccines. Heightened disease prevalence necessitates more widespread testing and treatment, accelerating product development. According to the European Centre for Disease Prevention and Control, as of November 2024, approximately 480,000 Chikungunya cases were reported worldwide, underscoring the expanding public health challenge.
Key Market Challenges
The persistent gap in surveillance capabilities and diagnostic readiness represents a significant impediment to the growth of the Global Chikungunya Fever Market. This challenge directly hampers the market by delaying timely detection and effective management of the disease, thereby limiting the demand for diagnostic solutions and subsequent therapeutic interventions. When infections go undetected or are misdiagnosed, the market for related products cannot expand to its full potential.
Key Market Trends
Advances in mRNA Vaccine Technology represent a pivotal trend, expediting the development cycle for Chikungunya vaccines by enabling rapid antigen identification and flexible manufacturing processes. This technology allows for quicker responses to emerging viral strains and offers the potential for high-efficacy profiles. According to *Vaccine*, in June 2023, Moderna's mRNA-1388 Chikungunya vaccine candidate demonstrated favorable safety and immunogenicity in a Phase 1 study, eliciting substantial and persistent neutralizing antibody responses in healthy adults.
Key Market Players
Quest Diagnostics, Inc.
Abbott Laboratories, Inc.
Genome Diagnostics Pvt. Ltd.
Altona Diagnostics GmbH
Bio-Rad Laboratories, Inc.
Taj Pharmaceuticals Ltd.
Etubics Corporation
Shanghai Solve Care Co. Ltd.
Report Scope:
In this report, the Global Chikungunya Fever Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Chikungunya Fever Market, By Diagnosis:
ELISA Based Assays
Serological Tests
Virological Tests
Chikungunya Fever Market, By Treatment:
Allopathy
Homeopathy
Ayurveda
Others
Chikungunya Fever Market, By End User:
Hospital & Clinics
Ambulatory Surgical care
Others
Chikungunya Fever Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Chikungunya Fever Market.
Available Customizations:
Global Chikungunya Fever Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Chikungunya Fever Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Diagnosis (ELISA Based Assays, Serological Tests, Virological Tests)
5.2.2. By Treatment (Allopathy, Homeopathy, Ayurveda, Others)
5.2.3. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Chikungunya Fever Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Diagnosis
6.2.2. By Treatment
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Chikungunya Fever Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Diagnosis
6.3.1.2.2. By Treatment
6.3.1.2.3. By End User
6.3.2. Canada Chikungunya Fever Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Diagnosis
6.3.2.2.2. By Treatment
6.3.2.2.3. By End User
6.3.3. Mexico Chikungunya Fever Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Diagnosis
6.3.3.2.2. By Treatment
6.3.3.2.3. By End User
7. Europe Chikungunya Fever Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Diagnosis
7.2.2. By Treatment
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Chikungunya Fever Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Diagnosis
7.3.1.2.2. By Treatment
7.3.1.2.3. By End User
7.3.2. France Chikungunya Fever Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Diagnosis
7.3.2.2.2. By Treatment
7.3.2.2.3. By End User
7.3.3. United Kingdom Chikungunya Fever Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Diagnosis
7.3.3.2.2. By Treatment
7.3.3.2.3. By End User
7.3.4. Italy Chikungunya Fever Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Diagnosis
7.3.4.2.2. By Treatment
7.3.4.2.3. By End User
7.3.5. Spain Chikungunya Fever Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Diagnosis
7.3.5.2.2. By Treatment
7.3.5.2.3. By End User
8. Asia Pacific Chikungunya Fever Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Diagnosis
8.2.2. By Treatment
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Chikungunya Fever Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Diagnosis
8.3.1.2.2. By Treatment
8.3.1.2.3. By End User
8.3.2. India Chikungunya Fever Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Diagnosis
8.3.2.2.2. By Treatment
8.3.2.2.3. By End User
8.3.3. Japan Chikungunya Fever Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Diagnosis
8.3.3.2.2. By Treatment
8.3.3.2.3. By End User
8.3.4. South Korea Chikungunya Fever Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Diagnosis
8.3.4.2.2. By Treatment
8.3.4.2.3. By End User
8.3.5. Australia Chikungunya Fever Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Diagnosis
8.3.5.2.2. By Treatment
8.3.5.2.3. By End User
9. Middle East & Africa Chikungunya Fever Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Diagnosis
9.2.2. By Treatment
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Chikungunya Fever Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Diagnosis
9.3.1.2.2. By Treatment
9.3.1.2.3. By End User
9.3.2. UAE Chikungunya Fever Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Diagnosis
9.3.2.2.2. By Treatment
9.3.2.2.3. By End User
9.3.3. South Africa Chikungunya Fever Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Diagnosis
9.3.3.2.2. By Treatment
9.3.3.2.3. By End User
10. South America Chikungunya Fever Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Diagnosis
10.2.2. By Treatment
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Chikungunya Fever Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Diagnosis
10.3.1.2.2. By Treatment
10.3.1.2.3. By End User
10.3.2. Colombia Chikungunya Fever Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Diagnosis
10.3.2.2.2. By Treatment
10.3.2.2.3. By End User
10.3.3. Argentina Chikungunya Fever Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Diagnosis
10.3.3.2.2. By Treatment
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Chikungunya Fever Market: SWOT Analysis
